VBI Vaccines (VBIV) Competitors

$0.60
-0.03 (-4.74%)
(As of 04/22/2024 ET)

VBIV vs. TRAW, COCP, KPRX, EDSA, NNVC, ORGS, PIRS, AYTU, AVTX, and IMNN

Should you be buying VBI Vaccines stock or one of its competitors? The main competitors of VBI Vaccines include Traws Pharma (TRAW), Cocrystal Pharma (COCP), Kiora Pharmaceuticals (KPRX), Edesa Biotech (EDSA), NanoViricides (NNVC), Orgenesis (ORGS), Pieris Pharmaceuticals (PIRS), Aytu BioPharma (AYTU), Avalo Therapeutics (AVTX), and Imunon (IMNN). These companies are all part of the "pharmaceutical preparations" industry.

VBI Vaccines vs.

VBI Vaccines (NASDAQ:VBIV) and Traws Pharma (NASDAQ:TRAW) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation, risk and community ranking.

Traws Pharma has lower revenue, but higher earnings than VBI Vaccines. Traws Pharma is trading at a lower price-to-earnings ratio than VBI Vaccines, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VBI Vaccines$8.68M1.98-$92.84M-$11.68-0.05
Traws Pharma$230K61.27-$18.95M-$0.91-0.74

VBI Vaccines received 500 more outperform votes than Traws Pharma when rated by MarketBeat users.

CompanyUnderperformOutperform
VBI VaccinesOutperform Votes
500
74.96%
Underperform Votes
167
25.04%
Traws PharmaN/AN/A

VBI Vaccines has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Comparatively, Traws Pharma has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500.

In the previous week, VBI Vaccines had 3 more articles in the media than Traws Pharma. MarketBeat recorded 3 mentions for VBI Vaccines and 0 mentions for Traws Pharma. Traws Pharma's average media sentiment score of 0.00 beat VBI Vaccines' score of -0.32 indicating that Traws Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
VBI Vaccines Neutral
Traws Pharma Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VBI Vaccines
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Traws Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

VBI Vaccines has a net margin of -1,069.29% compared to Traws Pharma's net margin of -8,384.07%. Traws Pharma's return on equity of -113.18% beat VBI Vaccines' return on equity.

Company Net Margins Return on Equity Return on Assets
VBI Vaccines-1,069.29% -234.77% -47.11%
Traws Pharma -8,384.07%-113.18%-65.76%

12.3% of VBI Vaccines shares are held by institutional investors. Comparatively, 8.0% of Traws Pharma shares are held by institutional investors. 10.4% of VBI Vaccines shares are held by insiders. Comparatively, 3.3% of Traws Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

VBI Vaccines beats Traws Pharma on 9 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VBIV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VBIV vs. The Competition

MetricVBI VaccinesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$17.14M$6.39B$4.71B$7.34B
Dividend YieldN/A3.11%5.49%3.98%
P/E Ratio-0.0517.33263.7020.30
Price / Sales1.98305.482,569.3783.30
Price / CashN/A19.0131.4527.23
Price / Book1.885.504.564.22
Net Income-$92.84M$139.94M$101.37M$213.35M
7 Day Performance-2.74%-2.16%-1.36%-0.42%
1 Month Performance4.83%-9.02%-6.71%-5.10%
1 Year Performance-81.13%-0.30%8.31%4.76%

VBI Vaccines Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRAW
Traws Pharma
0 of 5 stars
$0.70
-2.8%
N/AN/A$14.62M$230,000.00-0.76N/APositive News
COCP
Cocrystal Pharma
2.5725 of 5 stars
$1.46
+3.5%
$10.00
+584.9%
-38.7%$14.85MN/A-0.7312Gap Down
KPRX
Kiora Pharmaceuticals
2.1767 of 5 stars
$0.55
-1.8%
$7.00
+1,173.2%
-88.0%$14.44MN/A0.0012Positive News
EDSA
Edesa Biotech
2.2535 of 5 stars
$4.35
+4.6%
$39.00
+797.5%
-42.1%$13.99MN/A0.0016
NNVC
NanoViricides
0 of 5 stars
$1.18
+2.6%
N/A-18.5%$13.90MN/A-1.467Analyst Report
News Coverage
Gap Up
ORGS
Orgenesis
1.5475 of 5 stars
$0.50
flat
N/A-55.9%$15.94M$36.03M-0.55167Gap Down
PIRS
Pieris Pharmaceuticals
0.6399 of 5 stars
$0.16
-5.7%
N/A-81.7%$16.23M$42.81M-0.59127Analyst Report
Stock Split
AYTU
Aytu BioPharma
2.4436 of 5 stars
$2.92
+9.0%
$5.00
+71.2%
+3.0%$16.26M$107.40M-0.72150
AVTX
Avalo Therapeutics
0.28 of 5 stars
$15.94
+4.6%
N/A-98.2%$16.42M$1.92M-0.0320Gap Up
IMNN
Imunon
2.7316 of 5 stars
$1.37
-6.8%
$13.00
+848.9%
+1.6%$12.88M$500,000.00-0.6331Gap Up

Related Companies and Tools

This page (NASDAQ:VBIV) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners